Skip Navigation LinksHome   >   About   >   ESG

Environmental, Social and Governance

Our vision is to become the global leader in developing prescription medicines that target the endocannabinoid system and which address significant unmet medical needs.

OCT is strongly committed to its vision and to generating sustainable financial returns for its stakeholders and shareholders, and to integrating responsible investment and operational decisions with Environmental, Social and Governance considerations.

Work Environment and General Policy

Equal opportunities

Our Company is an equal opportunity employer.

At OCT we adhere to a policy, which enshrines that within the Company, and across its academic and business partners, responsible governance principles are followed. We ensure that people receive equal treatment, regardless of gender, gender-identity, age, disability, religion, belief, political views, sexual orientation, marital status, nationality or race, physical or mental health. We apply these principles to all areas of our business.


OCT believes that diversity is fundamental to the enrichment of our team and to the success of developing innovative therapeutic treatments. OCT is committed to creating a diverse environment, where the rights and differences of everyone, directly or indirectly operating within the Company, are valued.


OCT is committed to creating a positive, inclusive and welcoming work environment for its employees, job applicants, clients, customers, and affiliates. Consideration for others is a principle upheld and applied inside and outside of the workplace, which creates a safe and empowering work environment. OCT also ensures that its associates and collaborators adhere to the same approach by promoting and enabling similar policies.

Research Animal Care and Welfare

Our purpose is to research, develop and manufacture innovative pharmaceutical products. Due to scientific and regulatory reasons, animal studies remain a small but crucial part of our work to deliver safe and efficacious therapies, which benefit patients’ health and the wellbeing of our world.

The Company is actively engaging with partners, which develop and validate experimental methods that can provide alternatives to the use of animals in research. However, even though OCT, its scientific and business partners, and affiliates are eagerly adopting cutting-edge technology and coordinating efforts with legislators, regulators, and scientific institutions to completely eliminate the need for animal studies in their work, at present this is not possible, either due to lack of suitable alternatives, or because animal studies are required by regulatory authorities.

The Company ensures that any collaborator is strictly following international and local legislation and regulatory guidelines and does not perform procedures which are deemed unethical or illegal under The Animal Welfare Act 2006. We go above and beyond in our compliance with regulatory requirements, as OCT also enforces a voluntary ban on the testing on great apes (i.e., chimpanzees) in research, even in countries where it is legal to do so.

At OCT, we recognise the ethical responsibility to treat all animals respectfully, while striving to minimise their pain or distress, and to avoid it completely when possible. To this end, OCT is committed to following the high standards of internationally-recognised practices on the humane treatment of animals. We uphold and embrace the “3Rs” of animal research, namely:

  • The replacement of animals when possible and/or acceptable;
  • The reduction of the numbers of experiments and of animals required by each experiment; and,
  • The minimisation of pain and distress, by means of refinement of animal studies procedures

All animals used in OCT studies are specifically bred for research. In addition, all facilities where animals are bred, housed, or undergo procedures are accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (i.e., AAALAC-accredited) or are in the process of first accreditation and undergo regular visits by AAALAC. This ensures that all animal staff are competent, trained, continuously educated and assessed. OCT ensures that qualified veterinarians are available at all times for advice and help in the care of animals.

At OCT we do not work with or test cosmetics, food, or drink supplements

Environment, Health and Safety (EHS)

OCT affords great importance to supporting the wellbeing and health and safety of its employees and affiliates, and is continually looking for new and improved ways to maximise the positive impact that our work has on the environment and to best serve the needs of the global community.

We are strongly committed to conserving natural resources and striving for environmental sustainability, by ensuring that our facilities and the facilities of academic and contracted collaborators are operated to optimise energy usage; minimise waste production; and, protect nature and people.

OCT uses hazardous, or potentially hazardous, chemical and biological materials at every stage of its research and development. These materials are necessary for researching and identifying the causes and the cures to diseases and in the discovery of new, life-changing medicines.

The Company is, therefore, committed to ensuring that hazardous chemicals and biological materials are acquired, stored, transferred, modified, handled, and disposed of in a way that minimises any potential adverse effects to human health and to the environment. Their use must be based on both an understanding of the hazards they present and on the corresponding controls aimed at managing the risk of exposure

OCT complies with the local and national guidelines in all matters of EHS. The Company ensures its employees are knowledgeable and trained to identify and prevent risks and hazards associated with the use of substances hazardous to health and with any other aspect of its core business activities

In addition, OCT cooperates with its partners to make sure safe systems of work, local procedures, risk assessment, and relevant and continuous training are part of their standard operating procedures and that they take all reasonable steps to ensure all accidents, incidents, near-misses, and safety observations are reported and investigated in a timely fashion and that corrective measures are swiftly implemented.